Skip to main content

Advertisement

SpringerLink
Log in

Extent and nature of unlicensed and off-label medicine use in hospitalised children in Palestine

  • Research Article
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

Abstract

Objective of the study To determine the extent and nature of unlicensed/off-label prescribing patterns in hospitalised children in Palestine. Setting Four paediatric wards in two public health system hospitals in Palestine [Caritas children’s hospital (Medical and neonatal intensive care units) and Rafidia general hospital (Medical and surgical units)]. Method A prospective survey of drugs administered to infants and children <18 years old was carried out over a five-week period in the four paediatric wards. Main outcome measure Drug-licensing status of all prescriptions was determined according to the Palestinian Registered Product List and the Physician’s Desk Reference. Results Overall, 917 drug prescriptions were administered to 387children. Of all drug prescriptions, 528 (57.5%) were licensed for use in children; 65 (7.1%) were unlicensed; and 324 (35.3%) were used off-label. Of all children, 49.6% received off-label prescriptions, 10.1% received unlicensed medications and 8.2% received both. Seventy-two percent of off-label drugs and 66% of unlicensed drugs were prescribed for children <2 years. Multivariate analysis showed that patients who were admitted to the neonatal intensive care unit and infants aged 0–1 years were most likely to receive a greater number of off-label or unlicensed medications (OR 1.80; 95% CI 1.03–3.59 and OR 1.99; 95% CI 0.88–3.73, respectively). Conclusion The present findings confirmed the elevated prevalence of unlicensed and off-label paediatric drugs use in Palestine and strongly support the need to perform well designed clinical studies in children.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kearns GL, Abdel‐Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE. Developmental pharmacology‐drug disposition, action, therapy in infants and children. N Engl J Med. 2003;349:1157–67.

    Article  PubMed  CAS  Google Scholar 

  2. Conroy S, Choonara I, Impicciatore P, Mohn A, Arnell H, Rane A, et al. Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children. Br Med J. 2000;320:79–82.

    Article  CAS  Google Scholar 

  3. ‘t Jong GW, van der Linden PD, Bakker EM, van der Lely N, Eland IA, Stricker BH, et al. Unlicensed and off‐label drug use in a paediatric ward of a general hospital in the Netherlands. Eur J Clin Pharmacol. 2002;58:293–7.

    Article  PubMed  Google Scholar 

  4. Dell’Aera M, Gasbarro AR, Padovano M, Laforgia N, Capodiferro D, Solarino B, et al. Unlicensed and off‐label use of medicines at a neonatology clinic in Italy. Pharm World Sci. 2007;29:361–7.

    Article  PubMed  Google Scholar 

  5. Shah SS, Hall M, Goodman DM, Feuer P, Sharma V, Fargason C, et al. Off‐label drug use in hospitalized children. Arch Pediatr Adolesc Med. 2007;161:282–90.

    Article  PubMed  Google Scholar 

  6. Turner S, Nunn AJ, Fielding K, Choonara I. Adverse drug reactions to unlicensed and off‐label drugs on paediatric wards: a prospective study. Acta Paediatr. 1999;88:965–8.

    Article  PubMed  CAS  Google Scholar 

  7. Turner S, Nunn AJ, Choonara I. Unlicensed drug use in children in the UK. Paediatr Perinat Drug Ther. 1997;1:52–5.

    Google Scholar 

  8. McIntyre J, Conroy S, Avery A, Corns H, Choonara I. Unlicensed and off label prescribing of drugs in general practice. Arch Dis Child. 2000;83:498–501.

    Article  PubMed  CAS  Google Scholar 

  9. Royal College of Paediatrics and Child Health. The use of unlicensed medicines or licensed medicines for unlicensed applications in paediatric practice [Internet]. London: Royal College of Paediatrics and Child Health; 2002 [cited 2011 Jan 21]. Available from: www.rcpch.ac.uk/doc.aspx?id_Resource=7581.

  10. Mukattash T, Hawwa AF, Trew K, McElnay JC. Healthcare professional experiences and attitudes on unlicensed/off-label paediatric prescribing and paediatric clinical trials. Eur J Clin Pharmacol. 2011 [forthcoming].

  11. Cuzzolin L, Atzei A, Fanos V. Off‐label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety. Expert Opin Drug Saf. 2006;5:703–18.

    Article  PubMed  Google Scholar 

  12. Lindell-Osuagwu L, Korhonen MJ, Saano S, Helin-Tanninen M, Naaranlahti T, Kokki H. Off-label and unlicensed drug prescribing in three paediatric wards in Finland and review of the international literature. J Clin Pharm Ther. 2009;34:277–87.

    Article  PubMed  CAS  Google Scholar 

  13. Santos DB, Coelho LL, Clavenna AM. Off‐label and unlicensed drug utilization in hospitalized children in Fortaleza, Brazil. Eur J Clin Pharmacol. 2008;64:1111–8.

    Article  PubMed  Google Scholar 

  14. State of Palestine Ministry of Health. Palestinian essential drug list [Internet]. Nablus: Ministry of Health; 2006 [cited 2011 Jan 21]. Available from: http://pharmacy.moh.ps/index.php.

  15. Sifton DW. editor. Physicians’ Desk Reference. 62nd ed. Montvale: Medical Economics Company; 2008.

    Google Scholar 

  16. World Health Organization. The International statistical classification of diseases and related health problems (ICD), 10th Revision [Internet]. Geneva: WHO & DIMDI; 2006 [updated 2007; cited 2011 Jan 21]. Available from: http://apps.who.int/classifications/apps/icd/icd10online/.

  17. Avenel S, Bomkratz A, Dassieu G, Janaud JC, Danan C. The incidence of prescriptions without marketing product license in a neonatal intensive care unit. Arch Pediatr. 2000;7:143–7.

    Article  PubMed  CAS  Google Scholar 

  18. ‘t Jong GW, Vulto AG, de Hoog M, Schimmel KJ, Tibboel D, van den Anker JN. A survey of the use of off‐label and unlicensed drugs in a Dutch children’s hospital. Pediatrics. 2001;108:1089–93.

    Article  PubMed  Google Scholar 

  19. ‘t Jong GW, Vulto AG, de Hoog M, Schimmel KJ, Tibboel D, van den Anker JN. Unapproved, off‐label use of drugs in a children’s hospital. N Engl J Med. 2000;343:1125.

    Article  PubMed  Google Scholar 

  20. O’Donnell CP, Stone RJ, Morley CJ. Unlicensed and off‐label drug use in an Australian neonatal intensive care unit. Pediatrics. 2002;110:e52.

    Article  PubMed  Google Scholar 

  21. Carvalho PR, Carvalho CG, Alievi PT, Martinbiancho J, Trotta EA. Prescription of drugs not appropriate for children in a pediatric intensive care unit. Jornal de Pediatria. 2003;79:397–402.

    PubMed  Google Scholar 

  22. Neubert A, Lukas K, Leis T, Dormann H, Brune K, Rascher W. Drug utilisation on a preterm and neonatal intensive care unit in Germany: a prospective, cohort-based analysis. Eur J Clin Pharmacol. 2010;66:87–95.

    Article  PubMed  Google Scholar 

  23. Conroy S, McIntyre J, Choonara I. Unlicensed and off label drug use in neonates. Arch Dis Child Fetal Neonatal Ed. 1999 Mar;80(2):F142–4; discussion F144–5.

  24. Phan H, Leder M, Fishley M, Moeller M, Nahata M. Off-label and unlicensed medication use and associated adverse drug events in a pediatric emergency department. Pediatr Emerg Care. 2010;26:424–30.

    Article  PubMed  Google Scholar 

  25. Di Paolo ER, Stoetter H, Cotting J, Frey P, Gehri M, Beck‐Popovic M, et al. Unlicensed and offlabel drug use in a Swiss paediatric university hospital. Swiss Med Wkly. 2006;136:218–22.

    PubMed  Google Scholar 

  26. Chalumeau M, Treluyer JM, Salanave B, Brayley S, Thomson MB. Off label and unlicensed drug use among French office based paediatricians. Arch Dis Child. 2000;83:502–5.

    Article  PubMed  CAS  Google Scholar 

  27. Dick A, Keady S, Mohammad F, Brayley S, Thomson M, Lloyd BW, et al. Use of unlicensed and off‐label medications in paediatric gastroenterology with a review of the commonly used formularies in the UK. Aliment Pharmacol Ther. 2003;17:571–5.

    Article  PubMed  CAS  Google Scholar 

  28. Sawalha A. Self‐medication with antibiotics: a study in Palestine. Int J Risk Saf Med. 2008;20:213–22.

    Google Scholar 

  29. Khatib R, Gaicaman R. Treatment of infection: across sectional surveyof antibiotic drug utilization in the Ramallah district of Palestine. Int J Pharm Pract. 2006;14:211–7.

    Article  Google Scholar 

  30. Pandolfini C, Bonati M. A literature review on off‐label drug use in children. Eur J Pediatr. 2005;164:552–5.

    Article  PubMed  Google Scholar 

  31. Nascimento‐Carvalho CM, Souza‐Marques HH. Recommendation of the Brazilian society of pediatrics for antibiotic therapy in children and adolescents with community‐acquired pneumonia. Rev Panam Salud Publica. 2004;15:380–7.

    Article  PubMed  Google Scholar 

  32. Mulla H, Tofeig M, Bu’Lock F, Samani N, Pandya HC. Variations in captopril formulations used to treat children with heart failure: a survey in the United Kingdom. Arch Dis Child. 2007;92:409–11.

    Article  PubMed  Google Scholar 

  33. Conroy S. Extemporaneous (magistral) preparations of oral medicines for children in European hospitals. Acta Paediatr. 2003;92:408–41.

    Article  PubMed  CAS  Google Scholar 

  34. Benini F, Johnston C, Faucher D, Aranda JV. Topical anesthesia during circumcision in newborn infants. JAMA. 1993;270:850–3.

    Article  PubMed  CAS  Google Scholar 

  35. Parkinson L, Hughes J, Gill A, Billingham I, Ratcliffe J, Choonara I. A randomised controlled trial of sedation in the critically ill. Pediatr Anesth. 1997;7:405–10.

    Article  CAS  Google Scholar 

  36. Nahata MC. Licensing of medicines for children in the USA. Paediatr Perinat Drug Ther. 1997;1:50–1.

    Google Scholar 

  37. Kauffman RE. Status of drug approval processes and regulation of medi‐ cations for children. Curr Opinion Pediatr. 1995;7:195–8.

    Article  PubMed  CAS  Google Scholar 

  38. The European agency for the evaluation of medicinal products (EMEA). Medicines for children: the paediatric regulation [Internet]. Strasbourg: EMEA; 2006 [cited 2011 Jan 21]. Available from: http://ec.europa.eu/health/files/eudralex/vol‐1/reg_2006_1901/reg_2006_1901_en.pdf.

Download references

Acknowledgments

The authors wish to thank Dr Chris Cardwell, Department of Epidemiology and Public Health, Queen’s University Belfast, for his statistical support, Nursing & administrative staff at the Caritas and Rafidia hospitals.

Funding

The Daniel Turnberg UK/Middle East Travel Fellowship for financial support is acknowledged.

Conflicts of interest

None to declare.

Author information

Authors and Affiliations

  1. Faculty of Pharmacy, Al-Quds University, Abu-Dies, Jerusalem, P.O.Box 20002, Palestine

    Maher R. Khdour & Hussein Othman Hallak

  2. Faculty of Nursing, Al-Quds University, Abu-Dies, Jerusalem, P.O.Box 20002, Palestine

    Kawther Shab’an Atallah Alayasa

  3. Department of Pharmacy, Patient Friends Society/Al-Rahma PolyClinic, Nablus, Nablus, Palestine

    Qusai Nabeel AlShahed

  4. Clinical and Practice Research Group, School of Pharmacy, Medical Biology Centre, Queen’s University Belfast, 97 Lisburn Road, BT9 7BL, Belfast, UK

    Ahmed F. Hawwa & James C. McElnay

Authors
  1. Maher R. Khdour
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hussein Othman Hallak
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kawther Shab’an Atallah Alayasa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Qusai Nabeel AlShahed
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ahmed F. Hawwa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. James C. McElnay
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to James C. McElnay.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Khdour, M.R., Hallak, H.O., Alayasa, K.S.A. et al. Extent and nature of unlicensed and off-label medicine use in hospitalised children in Palestine. Int J Clin Pharm 33, 650–655 (2011). https://doi.org/10.1007/s11096-011-9520-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-011-9520-3

Keywords

Search

Navigation